Safo Jerzsele

Dr. Safo Jerzsele


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2016 in Future Medicinal Chemistry
Verified
Journal Article
Closed access
SJSafo Jerzsele
Safo Jerzsele
DSDeepika Sharma
Deepika Sharma
RBRanju Bansal
Ranju Bansal
In spite of the availability of a large number of anti-inflammatory and analgesic agents, fighting pain and inflammation remains a common problem. The current review article discusses the need of novel therapeutic targets for risk-free anti-inflammatory and analgesic therapy and summarizes some new agents in various stages of drug discovery pipeline. Pyridazin-3(2H)-ones are nitrogen-rich heterocyclic compounds of considerable medicinal interest due to their diverse biological activities. The current review article focuses on progressive development of this attractive scaffold for the design and synthesis of new pyridazinone-based anti-inflammatory and analgesic agents. Mechanistic insights into the anti-inflammatory and analgesic properties of pyridazinone derivatives and various synthetic techniques used for their synthesis are also described.

1 June 2020 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
SSSharma Shaveta
Sharma Shaveta
SJSafo Jerzsele
Safo Jerzsele
MAMuhammad Afzal
Muhammad Afzal
RKRupinder Kaur
Rupinder Kaur
Syed Sarim ImamSyed Sarim Imam
Syed Sarim Imam
AMAmeeduzzafar
Ameeduzzafar


23 November 2020 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
SJSafo Jerzsele
Safo Jerzsele
ASAmruta Suryan
Amruta Suryan
SKSandeep Kumar
Sandeep Kumar
SSShweta Sharma
Shweta Sharma
Phthalazinones are important nitrogen-rich heterocyclic compounds which have been a topic of considerable medicinal interest because of their diversified pharmacological activities. This versatile scaffold forms a common structural feature for many bioactive compounds, which leads to the design and development of novel anticancer drugs with fruitful results. The current review article discusses the progressive development of novel phthalazinone analogues that are targets for various receptors such as PARP, EGFR, VEGFR-2, Aurora kinase, Proteasome, Hedgehog pathway, DNA topoisomerase and P-glycoprotein. It describes mechanistic insights into the anticancer properties of phthalazinone derivatives and also highlights various simple and economical techniques for the synthesis of phthalazinones.


1 July 2017 in Indian Journal of Medical Microbiology
Verified
Journal Article
Open access
PDF file
ASAvinash Singh
Avinash Singh
SSSanjay Singh
Sanjay Singh
SJSafo Jerzsele
Safo Jerzsele
MRMohibur Rahman
Mohibur Rahman
APAshutosh Pathak
Ashutosh Pathak
KPKashi Nath Prasad
Kashi Nath Prasad
The aim of this study was to observe the survivability and fitness cost of heterogeneous vancomycin-intermediate Staphylococcus aureus(hVISA) isolates. Survivability study was performed on dry cotton swab, and fitness cost was evaluated by estimating growth kinetics and generation time constant in BACTEC automated system. Total mean maximum time of recovery on primary culture was 4.1 and 7.1 weeks (P = 0.0001) for hVISA and vancomycin-sensitive S. aureus (VSSA), respectively, in dry starved condition. No significant difference between the mean value of lag phase duration (P = 0.89) was noted between hVISA and VSSA isolate in growth kinetics. However, we observed lesser generation time of hVISA isolates compared to S. aureus ATCC 29213 (P = 0.0076). This study concluded that a significant difference in generation time between VSSA and hVISA and suggests that hVISA have fitness cost compared to VSSA. However, further studies with more cases are required.